143 related articles for article (PubMed ID: 15147218)
1. Anthrax protective antigen: efficiency of translocation is independent of the number of ligands bound to the prepore.
Zhang S; Cunningham K; Collier RJ
Biochemistry; 2004 May; 43(20):6339-43. PubMed ID: 15147218
[TBL] [Abstract][Full Text] [Related]
2. Characterization of membrane translocation by anthrax protective antigen.
Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
[TBL] [Abstract][Full Text] [Related]
3. Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.
Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Orlik F; Benz R
Biochemistry; 2006 Mar; 45(9):3060-8. PubMed ID: 16503661
[TBL] [Abstract][Full Text] [Related]
4. Self-association of the transmembrane domain of an anthrax toxin receptor.
Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
[TBL] [Abstract][Full Text] [Related]
5. Anthrax toxin.
Collier RJ; Young JA
Annu Rev Cell Dev Biol; 2003; 19():45-70. PubMed ID: 14570563
[TBL] [Abstract][Full Text] [Related]
6. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
[TBL] [Abstract][Full Text] [Related]
7. Membrane translocation by anthrax toxin.
Collier RJ
Mol Aspects Med; 2009 Dec; 30(6):413-22. PubMed ID: 19563824
[TBL] [Abstract][Full Text] [Related]
8. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
Young JA; Collier RJ
Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
[TBL] [Abstract][Full Text] [Related]
9. Anthrax toxins.
Mourez M
Rev Physiol Biochem Pharmacol; 2004; 152():135-64. PubMed ID: 15549606
[TBL] [Abstract][Full Text] [Related]
10. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
[TBL] [Abstract][Full Text] [Related]
11. Anthrax toxin complexes: heptameric protective antigen can bind lethal factor and edema factor simultaneously.
Pimental RA; Christensen KA; Krantz BA; Collier RJ
Biochem Biophys Res Commun; 2004 Sep; 322(1):258-62. PubMed ID: 15313199
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
13. Participation of residue F552 in domain III of the protective antigen in the biological activity of anthrax lethal toxin.
Khanna H; Gupta PK; Singh A; Chandra R; Singh Y
Biol Chem; 2001 Jun; 382(6):941-6. PubMed ID: 11501759
[TBL] [Abstract][Full Text] [Related]
14. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
[TBL] [Abstract][Full Text] [Related]
15. Assembly and disassembly kinetics of anthrax toxin complexes.
Christensen KA; Krantz BA; Collier RJ
Biochemistry; 2006 Feb; 45(7):2380-6. PubMed ID: 16475827
[TBL] [Abstract][Full Text] [Related]
16. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobic residues Phe552, Phe554, Ile562, Leu566, and Ile574 are required for oligomerization of anthrax protective antigen.
Ahuja N; Kumar P; Bhatnagar R
Biochem Biophys Res Commun; 2001 Sep; 287(2):542-9. PubMed ID: 11554763
[TBL] [Abstract][Full Text] [Related]
18. Activity of the Bacillus anthracis 20 kDa protective antigen component.
Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
[TBL] [Abstract][Full Text] [Related]
19. Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.
Juris SJ; Melnyk RA; Bolcome RE; Chan J; Collier RJ
Infect Immun; 2007 Oct; 75(10):5052-8. PubMed ID: 17635861
[TBL] [Abstract][Full Text] [Related]
20. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.
Cunningham K; Lacy DB; Mogridge J; Collier RJ
Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
